S&G Foundation’s Shattuck Labs STTK Stock Holding History

S&G Foundation’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.02M	Hold	435,749	–	–	0.14%	15
2026 Q1	$2.8M	Buy	+435,749	New	+$2.07M	0.15%	14

Other funds holding STTK

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

NCM

NEXTBio Capital Management Menlo Park, California $217M AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

S&G Foundation's STTK Position: Q2 2026 in Review

S&G Foundation held its Shattuck Labs (STTK) position steady in Q2 2026 at 435,749 shares worth $3.02M. The position accounts for 0.14% of the portfolio, ranked #15.

S&G Foundation first reported a position in STTK in Q1 2026 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

S&G Foundation held 435,749 shares of Shattuck Labs worth $3.02M as of Q2 2026.
S&G Foundation left its Shattuck Labs share count unchanged in Q2 2026.
Shattuck Labs made up 0.14% of S&G Foundation's portfolio in Q2 2026, its #15 holding.
S&G Foundation first reported a position in Shattuck Labs in Q1 2026 and has held it in 2 quarters since.
99 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on S&G Foundation's 13F filing for Q2 2026, filed 12 Aug 2026.